The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Phosphorylation Meets Ubiquitination: The Control of NF-κB Activity
Abstract
NF-kappaB (nuclear factor-kappaB) is a collective name for inducible dimeric transcription factors composed of members of the Rel family of DNA-binding proteins that recognize a common sequence motif. NF-kappaB is found in essentially all cell types and is involved in activation of an exceptionally large number of genes in response to infections, inflammation, and other stressful situations requiring rapid reprogramming of gene expression. NF-kappaB is normally sequestered in the cytoplasm of nonstimulated cells and consequently must be translocated into the nucleus to function. The subcellular location of NF-kappaB is controlled by a family of inhibitory proteins, IkappaBs, which bind NF-kappaB and mask its nuclear localization signal, thereby preventing nuclear uptake. Exposure of cells to a variety of extracellular stimuli leads to the rapid phosphorylation, ubiquitination, and ultimately proteolytic degradation of IkappaB, which frees NF-kappaB to translocate to the nucleus where it regulates gene transcription. NF-kappaB activation represents a paradigm for controlling the function of a regulatory protein via ubiquitination-dependent proteolysis, as an integral part of a phosphorylationbased signaling cascade. Recently, considerable progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1. The multisubunit Ika…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because of its ability to regulate the expression of inflammatory proteins, NFκB is believed to play a major role in the inflammatory process.”
From Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway (2007) · cites this paper as Karin and Ben-Neriah, 2000
In the citing paper
“NFκB-induced gene expression requires that NFκB not only becomes activated, but it must also be phosphorylated and must physically translocate from cytoplasm to the nucleus (Karin and Ben-Neriah, 2000).”
From Thymosin beta 4 suppression of corneal NFκB: A potential anti-inflammatory pathway (2007) · cites this paper as Karin and Ben-Neriah, 2000
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
The N-end rule: functions, mysteries, uses
Varshavsky, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12142 · Cited by 859
A CONSERVED SIGNALING PATHWAY: The Drosophila Toll-Dorsal Pathway
Belvin, M. P., & Anderson, K. V. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.393 · Cited by 836
A common human skin tumour is caused by activating mutations in β-catenin
Chan, E., Gat, U., McNiff, J. M., & Fuchs, E. (1999) · Nature Genetics · doi:10.1038/7747 · Cited by 612
A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB
Lee, S.-J., Dimtchev, A., Lavin, M. F., Dritschilo, A., & Jung, M. (1998) · Oncogene · doi:10.1038/sj.onc.1202088 · Cited by 136
Research works printed but not linked: 229
- 10.1016/0092-8674(86)90807-X · DOI
- Baldwin AS. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–81 · DOI
- Ghosh S, May MJ, Kopp EB. 1998. NFκB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225–60 · DOI
- 10.1016/S0065-230X(08)60257-2 · DOI
- 10.1146/annurev.cb.10.110194.002201 · DOI
- 10.1006/scbi.1997.0060 · DOI
- Whiteside ST, Israël A. 1997. I κ B proteins: structure, function and regulation. Semin. Cancer Biol. 8:75–82 · DOI
- 1997, J. Cell Sci., 110, 369, 10.1242/jcs.110.3.369 · DOI
- 10.1128/MCB.16.5.2341 · DOI
- 10.1101/gad.9.22.2736 · DOI
- 10.1084/jem.188.6.1055 · DOI
- 10.1038/34356 · DOI
- 10.1038/nsb0198-67 · DOI
- 10.1038/373303a0 · DOI
- 10.1038/373311a0 · DOI
- 10.1016/S0092-8674(00)81699-2 · DOI
- 10.1016/S0092-8674(00)81698-0 · DOI
- 10.1016/S0065-2776(08)60742-7 · DOI
- 10.1056/NEJM199704103361506 · DOI
- 10.1146/annurev.biochem.67.1.227 · DOI · Paper page
- 10.1146/annurev.immunol.15.1.749 · DOI · Paper page
- 1995, Microbiol. Rev., 59, 481, 10.1128/mr.59.3.481-505.1995 · DOI
- 10.1006/meth.1998.0646 · DOI
- Baichwal VR, Baeuerle PA. 1997. Activate NF-κB or die? Curr. Biol. 7:R94–96 · DOI
- 10.1006/scbi.1997.0062 · DOI
- 1996, Oncogene, 13, 1367
- 10.1006/scbi.1997.0061 · DOI
- Grilli M, Memo M. 1999. NF-κB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol. 57:1–7 · DOI
- 10.1073/pnas.95.14.8211 · DOI
- 10.1183/09031936.98.12010221 · DOI
- 10.1136/gut.43.6.856 · DOI
- 10.1128/MCB.15.5.2809 · DOI
- 10.1126/science.7878466 · DOI · Paper page
- 10.1128/MCB.15.3.1302 · DOI · Paper page
- 10.1128/MCB.16.4.1295 · DOI · Paper page
- 10.1002/j.1460-2075.1995.tb07287.x · DOI
- 10.1128/MCB.15.10.5339 · DOI
- 10.1038/25159 · DOI
- 10.1016/S0092-8674(00)80752-7 · DOI
- 10.1101/gad.13.5.505 · DOI
- 10.1101/gad.9.13.1586 · DOI
- 10.1073/pnas.92.24.11259 · DOI
- 10.1074/jbc.271.1.376 · DOI
- 10.1073/pnas.92.23.10599 · DOI
- Lin Y-C, Brown K, Siebenlist U. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκB: Signal-induced phosphorylation of IκB alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:3003–9 · DOI
- 10.1016/S0092-8674(00)80153-1 · DOI
- 10.1073/pnas.96.2.429 · DOI
- 10.1093/emboj/17.17.5170 · DOI
- 10.1073/pnas.95.22.13012 · DOI
- 10.1038/41493 · DOI · Paper page
- Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A. 1997. IKK-1 and IKK-2: cytokineactivated IκB kinases essential for NFκB activation. Science 278:860–66 · DOI
- 10.1016/S0092-8674(00)81064-8 · DOI
- 10.1016/S0092-8674(00)81842-5 · DOI
- 10.1016/S0092-8674(00)80406-7 · DOI
- 10.1016/S0092-8674(00)80344-X · DOI
- 10.1126/science.278.5339.866 · DOI
- 1995, Cell. Mol. Biol. Res., 41, 537
- 10.1038/26261 · DOI
- 10.1016/S0092-8674(00)81466-X · DOI
- 10.1128/MCB.19.2.1526 · DOI
- 10.1073/pnas.96.3.1042 · DOI
- 1990, J. Immunol., 145, 3080, 10.4049/jimmunol.145.9.3080 · DOI
- 10.1038/26254 · DOI
- 10.1046/j.1432-1327.1999.00028.x · DOI
- 10.1016/S1097-2765(00)80179-3 · DOI
- Zandi E, Chen Y, Karin M. 1998. Direct phosphorylation of IκB by IKKα and IKKβ: discrimination between free and NF-κB-bound substrate. Science 281:1360–63 · DOI
- 10.1126/science.284.5412.321 · DOI
- 10.1084/jem.189.11.1839 · DOI
- 10.1016/S1074-7613(00)80042-4 · DOI
- 10.1074/jbc.274.22.15297 · DOI
- 10.1074/jbc.273.20.12041 · DOI
- 10.1074/jbc.273.46.30736 · DOI
- 10.1073/pnas.95.7.3792 · DOI
- 10.1126/science.284.5412.309 · DOI
- 10.1016/S0092-8674(00)81092-2 · DOI
- 10.1128/MCB.19.3.2180 · DOI
- 10.1128/MCB.18.10.5899 · DOI
- 10.1038/43474 · DOI · Paper page
- 10.1038/43466 · DOI · Paper page
- 10.1128/MCB.18.12.7336 · DOI
- 10.1073/pnas.95.16.9319 · DOI
- 10.1128/MCB.19.1.21 · DOI
- 10.1023/A:1021925629248 · DOI
- 10.1038/18465 · DOI
- 10.1074/jbc.274.15.10641 · DOI
- 10.1038/385540a0 · DOI
- Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factorκB and c-jun N-terminal kinase (JNK/ SAPK) pathways at TNF receptor-associated factor 2. Proc. Natl. Acad. Sci. USA 94:9792–96 · DOI
- Baud V, Liu Z-G, Bennett B, Suzuki N, Xia Y, Karin M. 1999. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an N-terminal effector domain. Genes Dev. 13:1297– 308 · DOI
- 10.1126/science.284.5412.316 · DOI
- 10.1126/science.284.5412.313 · DOI
- 10.1038/8780 · DOI
- 10.1093/intimm/8.1.23 · DOI
- 10.1101/gad.12.21.3369 · DOI
- 10.1016/S1074-7613(00)80390-8 · DOI
- 10.1016/S1074-7613(00)80391-X · DOI
- 10.1073/pnas.95.5.2307 · DOI
- 10.1146/annurev.ge.29.120195.002103 · DOI
- 10.1101/gad.5.10.1892 · DOI
- 10.1016/0092-8674(91)90014-P · DOI
- 10.1038/ng0197-42 · DOI
- 10.1038/ng0197-36 · DOI
- 10.1038/376167a0 · DOI
- 10.1016/S1074-7613(00)80451-3 · DOI
- 10.1073/pnas.96.6.2994 · DOI
- Vandenabeele P, Declercg W, Beyaert R, Fiers W. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell. Biol. 5:392–99 · DOI · Paper page
- 10.1038/sj.onc.1202568 · DOI
- 10.1016/S0898-6568(98)00018-7 · DOI
- 10.1073/pnas.90.13.6155 · DOI
- Auron PE. 1998. The interleukin 1 receptor: ligand interactions and signal transduction. Cytokine Growth Factor Rev. 9:221–37 · DOI
- 10.1016/S1074-7613(00)80535-X · DOI · Paper page
- 10.1074/jbc.270.23.13757 · DOI
- Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7:837–47 · DOI
- Cao Z, Henzel WJ, Gao X. 1996. IRAK: a kinase associated with the interleukin1 receptor. Science 271:1128–31 · DOI
- 10.1126/science.278.5343.1612 · DOI
- 10.1038/383443a0 · DOI
- 10.1101/gad.12.18.2821 · DOI
- 10.1016/S1359-6101(98)00023-9 · DOI
- 10.1038/19110 · DOI
- 10.1126/science.7544915 · DOI
- Liu Z-G, Hu H, Goeddel DV, Karin M. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell 87:565– 76 · DOI · Paper page
- Takeuchi M, Rothe M, Goeddel DV. 1996. Anatomy of TRAF2: distinct domains for nuclear factor-κB activation and association with tumor necrosis factor signaling proteins. J. Biol. Chem. 16:19935–42 · DOI
- 10.1074/jbc.271.25.14661 · DOI
- 10.1101/gad.13.8.1015 · DOI
- 10.1074/jbc.273.35.22681 · DOI
- 10.1074/jbc.272.51.32102 · DOI
- 10.1126/science.275.5296.90 · DOI
- 10.1016/S1097-2765(00)80283-X · DOI
- 10.1016/S0959-437X(96)80062-1 · DOI
- 10.1006/scbi.1997.0059 · DOI
- 10.1006/dbio.1996.0308 · DOI
- 10.1038/35154 · DOI · Paper page
- 10.1016/S0014-5793(99)00322-1 · DOI
- 10.1042/0264-6021:3390227 · DOI
- 10.1016/S0952-7915(99)80003-X · DOI
- 10.1126/science.284.5418.1313 · DOI
- 10.1038/32195 · DOI
- Dushay MS, Asling B, Hultmark D. 1996. Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc. Natl. Acad. Sci. USA 93:10343–47 · DOI
- Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367–80 · DOI
- 10.1146/annurev.genet.30.1.405 · DOI
- 10.1146/annurev.biochem.67.1.425 · DOI · Paper page
- 10.1016/S0968-0004(97)01122-5 · DOI
- 10.1096/fasebj.11.14.9409544 · DOI
- 10.1016/0092-8674(93)90384-3 · DOI
- 10.1093/emboj/16.21.6325 · DOI · Paper page
- 10.1038/373081a0 · DOI
- 10.1038/10039 · DOI
- Zachariae W, Nosmyth K. 1999. Whose end is destruction: cell cycle division and the anaphase promoting complex. Genes Dev. 13:2039–58 · DOI
- Yamano H, Tsurumi C, Gannon J, Hunt T. 1998. The role of the destruction box and its neighbouring lysine residues in cyclin B for anaphase ubiquitin-dependent proteolysis in fission yeast: defining the D-box receptor. EMBO J. 17:5670– 78 · DOI
- 10.1016/S1097-2765(00)80126-4 · DOI
- 10.1016/S1097-2765(00)80286-5 · DOI
- Peters JM. 1998. SCF and APC: the yin and yang of cell cycle regulated proteolysis. Curr. Opin. Cell. Biol. 10:759–68 · DOI
- Patton EE, Willems AR, Tyers M. 1998. Combinatorial control in ubiquitindependent proteolysis: Don't Skp the Fbox hypothesis. Trends Genet. 14:236– 43 · DOI
- 10.1101/gad.13.12.1614 · DOI
- 10.1016/S1097-2765(00)80482-7 · DOI
- 10.1126/science.284.5414.657 · DOI
- 10.1038/20459 · DOI · Paper page
- 10.1128/MCB.18.2.732 · DOI
- 10.1126/science.284.5414.662 · DOI
- 10.1128/MCB.16.3.1058 · DOI
- 10.1093/emboj/16.21.6486 · DOI
- 10.1101/gad.7.7a.1266 · DOI
- 10.1002/j.1460-2075.1993.tb06157.x · DOI
- 10.1093/emboj/16.13.3797 · DOI
- 10.1126/science.275.5307.1790 · DOI
- 10.1126/science.275.5307.1787 · DOI
- 1998, Cancer Res., 58, 1344
- 10.1002/(SICI)1098-2264(199805)22:1<37::AID-GCC5>3.3.CO;2-P · DOI
- 1998, Cancer Res., 58, 2524
- 1998, Cancer Res., 58, 896
- 1998, Cancer Res., 58, 2520
- 1998, Cancer Res., 58, 1130
- 10.1073/pnas.95.15.8847 · DOI
- Spevak W, Keiper BD, Stratowa C, Castanon MJ. 1993. Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with beta-transducin repeats. Mol. Cell. Biol. 13:4953–66. Erratum. 1993. 13(11):7199 · DOI
- 10.1016/S1097-2765(00)80056-8 · DOI
- 10.1006/bbrc.1999.0289 · DOI
- 10.1073/pnas.96.7.3859 · DOI
- 10.1074/jbc.274.12.7941 · DOI
- 10.1101/gad.13.3.284 · DOI
- 10.1101/gad.13.21.2751 · DOI
- 10.1038/sj.onc.1202760 · DOI
- 10.1016/S0092-8674(00)81376-8 · DOI
- 1996, Nature, 379, 847
- 10.1038/360597a0 · DOI
- 10.1006/geno.1999.5792 · DOI
- 10.1016/S0960-9822(99)80091-8 · DOI
- 10.1093/emboj/18.9.2401 · DOI
- 10.1038/sj.onc.1202653 · DOI
- 10.1073/pnas.96.11.6273 · DOI
- 10.1016/S0925-4773(98)00134-8 · DOI
- 10.1016/S0304-419X(97)00008-5 · DOI
- 10.1016/S0165-4608(97)00479-2 · DOI
- 10.1002/(SICI)1098-2264(199808)22:4<295::AID-GCC5>3.3.CO;2-R · DOI
- 10.1038/sj.onc.1202073 · DOI
- 10.1126/science.274.5288.782 · DOI · Paper page
- Wang C-Y, Mayo MW, Baldwin AS Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784–87 · DOI
- 10.1016/S0092-8674(00)81409-9 · DOI
- 10.1038/354395a0 · DOI
- 10.1016/S0092-8674(94)90482-0 · DOI
- Orian A, Whiteside S, Israël A, Stancovski I, Schwartz AL, Ciechanover A. 1995. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105: reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. J. Biol. Chem. 270:21707– 14 · DOI
- 10.1074/jbc.273.15.8820 · DOI
200 of 229 shown
Cited by
Sorted by citations
Items 301–400 of 1,071
Toxoplasma gondii manipulates host cell signaling pathways via its secreted effector molecules.
Ihara, F., & Nishikawa, Y. (2021) · Parasitology international · doi:10.1016/j.parint.2021.102368 · Cited by 38
Nuclear Factor Kappa B in Autism Spectrum Disorder: A Systematic Review
Liao, X., & Li, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104918 · Cited by 37
Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors
Li, P., & Liu, H.-M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112107 · Cited by 50
Zhang, R.-L., Chen, J., Mao, X., Qi, P., & Zhang, X. (2019) · Marine Drugs · doi:10.3390/md17100586 · Cited by 38
Han, L.-R., Lei, H.-Z., Tian, Z., Wang, X., Cheng, D., & Wang, C.-L. (2018) · Food & Function · doi:10.1039/c8fo00269j · Cited by 38
Kroismayr, A., Sehm, J., Pfaffl, M., Schedle, K., Plitzner, C., & Windisch, W. (2018) · Czech Journal of Animal Science · doi:10.17221/338-cjas · Cited by 38
“It is found essentially in all cell types and is involved in the activation of a large number of genes in response to infections, inflammation and other stressful situations such as AIDS, asthma and cancer (Karin and Ben-Neriah, 2000; Baldwin, 2001).”
BackgroundChen, X.-Y., Dou, Y., Luo, D.-D., Zhang, Z., Li, C.-L., Zeng, H.-F., Su, Z.-R., Xie, J.-H., Lai, X., & Li, Y.-C. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.001 · Cited by 38
Yan, W., Bi, H.-L., Liu, L.-X., Li, N.-N., Liu, Y., Du, J., Wang, H.-X., & Li, H.-H. (2017) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2017.05.011 · Cited by 38
Heusinger, E., & Kirchhoff, F. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00198 · Cited by 40
“The remaining two factors (NF-κB1 and NF-κB2) are synthesized as large inactive precursors (p105 and p100) that need to undergo proteasomal degradation of their ankyrin repeat containing C-terminal region to generate the mature p50 and p52 NFκB subunits, respectively (Karin and Ben-Neriah, 2000).”
BackgroundImmunoregulation and male reproductive function: Impacts and mechanistic insights into inflammation
Ma, Y., Yu, X., Liu, Y. F., Song, B., Sun, Z., & Zhao, S. (2024) · Andrology · doi:10.1111/andr.13772 · Cited by 35
Cornwell, A., Ziółkowski, H., & Badiei, A. (2023) · Biomolecules · doi:10.3390/biom13050770 · Cited by 38
Lin, Z., Yang, C., Wang, R., Du, J., Volovych, O., Li, J., Hu, Y., Lu, Z., Lu, Z., & Zou, Z. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02301 · Cited by 42
Cristina, A., Leonte, D., Vlase, L., Bencze, L., Imre, S., Marc, G., Apan, B., Mogoșan, C., & Zaharia, V. (2018) · Molecules · doi:10.3390/molecules23102425 · Cited by 37
“NF-κB is a major transcription factor for regulating the expressions of proinflammatory enzymes and cytokines (iNOS, COX-2 and TNF-α) [41].”
High-fat diet inhibits PGC-1α suppressive effect on NFκB signaling in hepatocytes
Barroso, W. A., Victorino, V. J., Jeremias, I. C., Petroni, R., Ariga, S. K. K., Salles, T. A., Barbeiro, D. F., de Lima, T. M., & de Souza, H. P. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1472-5 · Cited by 48
Kim, E., Kang, Y.-G., Kim, J., Kim, Y.-J., Lee, T. R., Lee, J., Kim, D.-H., & Cho, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071828 · Cited by 37
Yousef, B. A., Hassan, H. M., Zhang, L., & Jiang, Z. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.01.008 · Cited by 48
Cai, J., Xu, D., Bai, X., Pan, R., Wang, B., Sun, S., Chen, R., Sun, J., & Huang, Y. X. (2017) · Brain and Behavior · doi:10.1002/brb3.790 · Cited by 33
Paeonol alleviates ulcerative colitis by modulating PPAR-γ and nuclear factor-κB activation
Cheng, S.-Y., Chen, W., Guo, Z., Ding, C., Zuo, R., Liao, Q., & Liu, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-68992-6 · Cited by 38
Ju, Z.-R., Su, M., Hong, J., Kim, E. L., Moon, H., Chung, H., Kim, S., & Jung, J. H. (2019) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2019.07.016 · Cited by 36
Lawal, A., Oluyede, D. M., Adebimpe, M. O., Olumegbon, L. T., Awolaja, O. O., Elekofehinti, O., & Crown, O. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01426 · Cited by 36
Interleukin-1 in the Response of Follicular Helper and Follicular Regulatory T Cells
Ritvo, P.-G., & Klatzmann, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00250 · Cited by 38
“This ultimately activates the expression of pro-inflammatory genes such as cytokines, chemokines and adhesion molecules (17).”
BackgroundLimongi, D., Baldelli, S., Checconi, P., Marcocci, M. E., Chiara, G. D., Fraternale, A., Magnani, M., Ciriolo, M., & Palamara, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00155 · Cited by 36
“Moreover, we analyzed the IκB kinase (IKKα/β), which by phosphorylating IKB-α leads to its degradation (50).”
Isorhynchophylline alleviates learning and memory impairments induced by aluminum chloride in mice
Li, H., Ip, S., Zheng, G., Xian, Y., & Lin, Z. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0187-8 · Cited by 39
Anti-inflammatory coumarins from Paramignya trimera
Anh, H. L. T., Kim, D., Ko, W., Ha, T. M., Nhiệm, N. X., Yến, P. H., Tài, B. H., Truong, L. H., Long, V. N., Gioi, T., et al. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1296001 · Cited by 51
“The mechanism of action of the compounds on NF-jB signalling may be conducted in a further study.”
BackgroundInfluentialLiu, C., Zhao, J., Liu, Y., Huang, Y., Shen, Y., Wang, J., Sun, W., & Sun, Y. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.024 · Cited by 38
Lukas, K., Nguyen, J., Necas, C., Dave, K., & Venketaraman, V. (2025) · Pharmaceuticals · doi:10.3390/ph18111764 · Cited by 35
Meng, Q., Wei, K., & Shan, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433898 · Cited by 44
Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease
Pan, X., Wu, S., Wei, W., Chen, Z., Wu, Y., & Gong, K. (2022) · Biomolecules · doi:10.3390/biom12070910 · Cited by 41
Romero, N., Waesberghe, C. V., & Favoreel, H. W. (2020) · Journal of Virology · doi:10.1128/jvi.00196-20 · Cited by 34
Peñalver, P., Zodio, S., Lucas, R., de‐Paz, M. ‐., & Morales, J. C. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b07147 · Cited by 38
Wei, Z., Chen, G.-C., Zhang, P.-Y., Zhu, L., Zhang, L.-N., & Chen, K.-S. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.06.076 · Cited by 35
Xing, Z.-H., He, Z.-M., Wang, S., Yan, Y., Zhu, H.-Y., Gao, Y.-G., Zhao, Y., & Zhang, L.-X. (2018) · RSC Advances · doi:10.1039/c8ra05356a · Cited by 35
Dual Roles for Ikaros in Regulation of Macrophage Chromatin State and Inflammatory Gene Expression
Oh, K., Gottschalk, R. A., Lounsbury, N., Sun, J., Dorrington, M. G., Baek, S., Sun, G., Wang, Z., Krauss, K. S., Milner, J. D., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800158 · Cited by 39
Schwarz, A., Bonaterra, G., Schwarzbach, H., & Kinscherf, R. (2017) · Journal of Biomedical Sciences · doi:10.1186/s12929-017-0320-5 · Cited by 35
“(PDF 264 kb) Additional file 5: OxLDL-induced NF-κB signaling in human MФ after 24 h. (PDF 340 kb) Abbreviations ABCA1: ATP-binding cassette protein A1; ANOVA: Analysis of variance; apoA1: Apolipoprotein A-1; apoE: Apolipoprotein E; BCA: Bicinchoninic acid; CCL2: C-C motif chemokine ligand 2; CE: Cholesteryl ester; CE…”
BackgroundHistone deacetylase 4 inhibits NF-κB activation by facilitating IκBα sumoylation
Yang, Q., Tang, J., Xu, C., Zhao, H., Zhou, Y., Wang, Y., Yang, M., Chen, X., & Chen, J. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa043 · Cited by 35
Helmy, Y. A., Kassem, I. I., & Rajashekara, G. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1857514 · Cited by 42
MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis
Yu, X., Li, W., Deng, Q., Liu, H., Wang, X., Hu, H., Cao, Y., Xu-Monette, Z. Y., Li, L., Zhang, M., et al. (2020) · Blood · doi:10.1182/blood.2020004918 · Cited by 43
Probiotic mediated NF-κB regulation for prospective management of type 2 diabetes
Bhardwaj, R., Singh, B. P., Sandhu, N., Singh, N., Kaur, R., Rokana, N., Singh, K. S., Chaudhary, V., & Panwar, H. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05254-4 · Cited by 38
Agomelatine prevents indomethacin-induced gastric ulcer in rats
Eraslan, E., Tanyeli̇, A., Güler, M. C., Kurt, N., & Yetim, Z. (2020) · Pharmacological Reports · doi:10.1007/s43440-019-00049-2 · Cited by 32
Ubiquitination in melanoma pathogenesis and treatment
Ma, J., Guo, W., & Li, C. (2017) · Cancer Medicine · doi:10.1002/cam4.1069 · Cited by 35
Wang, X., Wang, R., Luo, M., Li, C., Wang, H.-X., Huan, C., Qu, Y., Liao, Y., & Mao, X. (2017) · Oncotarget · doi:10.18632/oncotarget.16593 · Cited by 33
“NF-κB mainly distributes in the cytoplasm by interacting with the inhibitory IκB proteins (IκBα, IκBβ, IκBɛ and Bcl-3) [43].”
Serum- and Glucocorticoid-Inducible Kinase 1 Sensitive NF-κB Signaling in Dendritic Cells
Schmid, E., Xuan, N. T., Zahir, N., Russo, A., Yang, W., Kuhl, D., Faggio, C., Shumilina, E., & Lang, F. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366311 · Cited by 33
Kuang, S.-D., Liu, Z.-W., Liu, L., Fu, X., Sheng, W., Hu, Z., Lin, C., He, Q.-H., Chen, J., & Gao, S.-G. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133137 · Cited by 33
Zheng, Q., Wang, D., Lin, R., Lv, Q., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013322 · Cited by 38
Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
Zhu, Z., Fang, C., Xu, H., Yuan, L., Du, Y., Ni, Y., Xu, Y., Shao, A., Zhang, A., & Lou, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.976557 · Cited by 37
Milani, D., Caruso, L., Zauli, E., Owaifeer, A. M. A., Secchiero, P., Zauli, G., Gemmati, D., & Tisato, V. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.871583 · Cited by 37
Yang, F., Chen, R., Li, W.-Y., Zhu, H.-Y., Chen, X.-X., Hou, Z.-F., Cao, R.-S., Zang, G., Li, Y., & Zhang, W. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.591830 · Cited by 26
Plant Polyphenols-Biofortified Foods as a Novel Tool for the Prevention of Human Gut Diseases
Scarano, A., Chieppa, M., & Santino, A. (2020) · Antioxidants · doi:10.3390/antiox9121225 · Cited by 40
“Other signaling pathways modulated by polyphenols participate to the inflammatory responses, proliferation and apoptosis, as in the case of the NFkB signaling pathway (Nuclear Factor kappa-light-chain enhancer of activated B cells [59]), and the MAP kinases pathway (Mitogen-Activated Protein kinase; [3,60]).”
BackgroundCharacterization of the black carp TRAF6 signaling molecule in innate immune defense
Jiang, S., Xiao, J., Li, J., Chen, H., Wang, C., Feng, C., & Feng, H. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.06.011 · Cited by 35
Li, B., Yang, Y.-A., Chen, L., Chen, S.-C., Zhang, J., & Tang, W.-J. (2017) · MedChemComm · doi:10.1039/c7md00210f · Cited by 33
Shi, Z., Chen, Y., Lu, C., Dong, L.-M., Lv, J.-W., Tuo, Q.-H., Qin, L., Cheng, S.-W., Bu, L.-L., Lin, N., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.09.002 · Cited by 32
Gao, J., Cao, B., Zhao, R., Li, H., Xu, Q., & Wei, B. (2023) · Pharmaceuticals · doi:10.3390/ph16091216 · Cited by 40
Yu, G.-R., Yu, H.-S., Yang, Q., Wang, J.-X., Fan, H., Liu, G., Wang, L., Bello, B., Zhao, P.-P., Zhang, H.-G., et al. (2021) · Developmental and Comparative Immunology · doi:10.1016/j.dci.2021.104292 · Cited by 32
Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases.
Mehta, M., Paudel, K., Shukla, S., Allam, V., Kannaujiya, V., Panth, N., Das, A., Parihar, V., Chakraborty, A., Ali, M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.010 · Cited by 32
“IκKB subunit of the IKK complex which in turn results in the ubiquitination and phosphorylation of two N-terminal serine residues of IκBα proteins [36].”
BackgroundQiao, G., Lv, T., Zhang, M., Chen, P., Sun, Q., Zhang, J., & Li, Q. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.11.005 · Cited by 33
Bastin, A., Sadeghi, A., Nematollahi, M., Abolhassani, M., Mohammadi, A., & Akbari, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30049 · Cited by 32
Mannan-Binding Lectin Suppresses Peptidoglycan-Induced TLR2 Activation and Inflammatory Responses
Wang, F., Lǐ, Y., Yang, C., Mu, Y., Wang, Y., Zhang, W., Yang, Y., Chen, C., Song, S., Shen, Z., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/1349784 · Cited by 30
Mollugin Has an Anti-Cancer Therapeutic Effect by Inhibiting TNF-α-Induced NF-κB Activation
Wang, Z., Li, M.-Y., Mi, C., Wang, K.-S., Ma, J., & Jin, X.-J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081619 · Cited by 32
Jang, J., Jung, Y., Chae, S., Chung, S.-I., Kim, S.-M., & Yoon, Y. (2017) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2017.01.156 · Cited by 32
“It is well-known that TNF-a activates intracellular signaling events leading to phosphorylation of IkB followed by its degradation, which frees NF-kB for translocation into the nucleus [3,6].”
BackgroundChen, P., Wang, R., Liu, F., Li, S., Gu, Y., Wang, L., & Yuan, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1092151 · Cited by 23
Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ
Gan, J., Guo, L., Zhang, X., Yu, Q., Yang, Q., Zhang, Y., Zeng, W., Jiang, X., & Guo, M. (2023) · Journal of Inflammation · doi:10.1186/s12950-023-00330-5 · Cited by 38
“TNF-α, IL-1, and LPS all fail to activate NF-κB [38].”
BackgroundCopper homeostasis and the ubiquitin proteasome system
Zhang, B., & Burke, R. (2023) · Metallomics · doi:10.1093/mtomcs/mfad010 · Cited by 36
Intersection of the Ubiquitin–Proteasome System with Oxidative Stress in Cardiovascular Disease
Qiu, M., Chen, J., Li, X., & Zhuang, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012197 · Cited by 43
Kim, D. B., Unenkhuu, B., Kim, G. J., Kim, S.-W., & Kim, H. S. (2022) · Animal Cells and Systems · doi:10.1080/19768354.2022.2077438 · Cited by 33
“Extracellular proinflammatory stimuli cause IκB to be phosphorylated and degraded; as a result, free NF-κB is translocated to the nucleus, stimulating the expression of downstream genes (Karin and Ben-Neriah 2000).”
BackgroundIntegrative Proteomic Analysis of Multiple Posttranslational Modifications in Inflammatory Response
Ji, F., Zhou, M., Zhu, H., Jiang, Z., Li, Q., Ouyang, X., Lv, Y., Zhang, S., Wu, T., & Li, L. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.11.004 · Cited by 37
“Phosphorylation is a widely investigated type of PTMs in innate immunity [4].”
Dai, X., Nie, G., Cao, H., Xing, C., Hu, G., & Zhang, C. (2019) · Poultry Science · doi:10.3382/ps/pez328 · Cited by 33
Nitrated fatty acids: from diet to disease
Khoo, N., & Schopfer, F. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.04.013 · Cited by 31
Wan, D., Wu, Q.-H., Qu, W., Liu, G., & Wang, X. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1324173 · Cited by 31
Biomarkers in abnormal uterine bleeding†
Chodankar, R., & Critchley, H. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy231 · Cited by 31
“The canonical pathway is triggered by microbial products and proinflammatory cytokines such as TNFα and IL-1, while the alternative pathway is triggered by TNF-family cytokines but not TNFα [51, 52].”
BackgroundInfluentialYoon, C.-S., Kim, D.-C., Park, J.-S., Kim, K.-W., Kim, Y.-C., & Oh, H. (2018) · Molecules · doi:10.3390/molecules23092367 · Cited by 31
“Therefore, suppression of the NF-κB pathway is a widely used strategy for inhibiting neuroinflammation [21,22].”
MethodLi, C., Chen, T., Zhou, H., Feng, Y., Hoi, M. P. M., Ma, D., Zhao, C., Zheng, Y., & Lee, S. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00614 · Cited by 32
“The activated microglia-mediated neuroinflammatory responses are characterized by pro-inflammatory molecule production, which is well known to be regulated by the transcription factor NF-κB signaling pathway (Baeuerle and Henkel, 1994; Karin and Ben-Neriah, 2000).”
BackgroundChen, Y.-F., Ji, N., Pan, S., Zhang, Z., Wang, R., Qiu, Y.-L., Jin, M.-H., & Kong, D. (2017) · Inflammation · doi:10.1007/s10753-017-0636-z · Cited by 31
Integrating novel drugs to chemoimmunotherapy in diffuse large B-cell lymphoma
Chiappella, A., Santambrogio, E., Castellino, A., Nicolosi, M., & Vitolo, U. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1350164 · Cited by 31
Horodincu, L., & Solcan, C. (2023) · Animals · doi:10.3390/ani13132095 · Cited by 38
A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
Sarohan, A. R., Kızıl, M., İnkaya, A. Ç., Mahmud, S. O., Akram, M., & Çen, O. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110121 · Cited by 44
Mostafizar, M., Cortes-Pérez, C. M., Snow, W. M., Djordjevic, J., Adlimoghaddam, A., & Albensi, B. C. (2021) · Cells · doi:10.3390/cells10061335 · Cited by 36
“For example, NF-κB subunits are not exclusively localized in the nucleus of a cell [64], and NF-κB signaling involves several steps, as follow: the activation of IKK [65], IκB degradation [66] and ubiquitination [67], post-translational modification of the NF-κB subunits [68,69], and translocation of the NF-κB dimers…”
Ma, Q.-H., Ren, M.-Y., & Luo, J.-B. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112800 · Cited by 30
Liu, J., Tang, J., Li, X., Yan, Q., Ma, J.-W., & Jiang, Z.-Q. (2019) · Molecules · doi:10.3390/molecules24234251 · Cited by 30
“In the innate immune system of the host, NO could serve as the killer of infected cells, tumor cells, and parasitic pathogens [37].”
BackgroundFei, X., Chen, C., Kai, S., Fu, X., Man, W., Ding, B., Wang, C., & Xu, R. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105837 · Cited by 33
Đorđević, M., Grdović, N., Mihailović, M., Јovanović, J. A., Uskoković, A. S., Rajić, J., Đorđević, M., Tolić, A., Mišić, D. M., Šiler, B., et al. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112043 · Cited by 32
Wang, W., Wu, Y., Chen, X., Zhang, P., Li, H., & Chen, L.-X. (2019) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2018.11.002 · Cited by 30
Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.
Nejad, L. D., Biglari, A., Annese, T., & Ribatti, D. (2017) · Oncology Letters · doi:10.3892/ol.2017.5960 · Cited by 30
“In response to certain stimulatory agents, including viral infection, inflammatory cytokines and bacterial lipopolysaccharide, I κ Bs are rapidly phosphorylated and degraded to promote the nuclear transfer of NF-κ B and the activation of a number of genes (34,35).”
Zou, M.-J., Wang, F., Jiang, A.-Q., Xia, A.-L., Kong, S., Gong, C.-S., Zhu, M.-X., Zhou, X., Zhu, J., Zhu, W.-G., et al. (2017) · Helicobacter · doi:10.1111/hel.12348 · Cited by 30
Rho kinase inhibition ameliorates cyclophosphamide-induced cystitis in rats
Wróbel, A., Doboszewska, U., Rechberger, E., Rojek, K., Serefko, A., Poleszak, E., Skalicka-Wożniak, K., Dudka, J., & Wlaź, P. (2017) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-017-1361-8 · Cited by 30
“It was shown that pre-treatment with antiTNF-α or anti-IL-1β serum diminished mucosal erosion, hemorrhage, edema, leukocyte migration, and ulceration in CYP-injected mice (Gomes et al. 1995).”
BackgroundInfluentialGautam, A., Gupta, S., Mehndiratta, M., Sharma, M., Singh, K., Kalra, O. P., Agarwal, S., & Gambhir, J. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i2.66 · Cited by 30
Progress on innate immune evasion and live attenuated vaccine of pseudorabies virus
Nie, Z., Zhu, S., Wu, L., Sun, R., Shu, J., He, Y., & Feng, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1138016 · Cited by 32
Saroj, P., Bansal, Y., Singh, R., Akhtar, A., Sodhi, R. K., Bishnoi, M., Sah, S. P., & Kuhad, A. (2021) · Inflammopharmacology · doi:10.1007/s10787-020-00787-3 · Cited by 32
Ali, I., Yang, M., Wang, Y., Yang, C., Shafiq, M., Wang, G., & Li, L. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119138 · Cited by 29
The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancers
Gouravani, M., Khalili, N., Razi, S., Keshavarz‐Fathi, M., Khalili, N., & Rezaei, N. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1713755 · Cited by 33
Huang, C.-Y., Wang, Y., He, X., Jiao, N., Zhang, X., Qiu, K., Piao, X., & Yin, J.-D. (2019) · British Journal of Nutrition · doi:10.1017/s0007114519000928 · Cited by 29
Tu, H., Zhang, D., & Li, Y. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0274-y · Cited by 31
Karati, D., Meur, S., Roy, S., Mukherjee, S., Debnath, B., Jha, S. K., Sarkar, B. K., Naskar, S., & Ghosh, P. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03500-1 · Cited by 31
“Two important kinases, IKKα and IKKβ, compose the catalytic domains of the IκB kinase (IKK) complex (Karin and Ben-Neriah 2000; Medunjanin et al. 2016).”
Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review)
Wang, Z., Chang, Y., Sun, H., Li, Y., & Tang, T. (2024) · Oncology Letters · doi:10.3892/ol.2024.14390 · Cited by 34
“This activity is similar to the function of IKKβ in myeloid cells.”
InfluentialExploring sulforaphane as neurotherapeutic: targeting Nrf2-Keap & Nf-Kb pathway crosstalk in ASD
Shah, A., Varma, M., & Bhandari, R. (2023) · Metabolic brain disease · doi:10.1007/s11011-023-01224-4 · Cited by 28
“The IκBs mask the nuclear localization sequences of NF-κB and create problems with recognition of the NF-κB nuclear localization signal (NLS) by the nuclear import machinery, as a result retaining NF-κB in the cytoplasm (Karin and Ben-Neriah 2000).”
Zhou, X., Du, H.-H., Long, X., Pan, Y., Hu, J. P., Yu, J., & Zhao, X. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s327329 · Cited by 29
Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging
Moreira‐Pais, A., Ferreira, R. M., Oliveira, P. A., & Duarte, J. A. (2021) · Biogerontology · doi:10.1007/s10522-021-09932-z · Cited by 31
Dong, L., Hu, R., Yang, D., Zhao, J., Kan, H., Tan, J., Guan, M., Kang, Z., & Xu, F. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.46962 · Cited by 27
“NF-κB-mediated gene expression can also regulate the production of inflammatory mediators [25].”
BackgroundOta, M., Tanaka, Y., Nakagawa, I., Jiang, J., Arima, Y., Kamimura, D., Onodera, T., Iwasaki, N., & Murakami, M. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41182 · Cited by 35
Kany, S., Janicova, A., & Relja, B. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111981 · Cited by 39
“IKK phosphorylates IkB, thus exposing it to disassembly via ubiquitination [36].”
BackgroundHSP70/DNAJA3 chaperone/cochaperone regulates NF-κB activity in immune responses.
Kumada, K., Fuse, N., Tamura, T., Okamori, C., & Kurata, S. (2019) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2019.04.077 · Cited by 28
Metadata
- Authors
- Karin, M., & Ben-Neriah, Y.
- Affiliations
- Hebrew University of Jerusalem (IL)
- Department of Pharmacology, Laboratory of Gene Regulation and Signal Transduction University of California, San Diego, La Jolla, California, 92093-0636;
- ORCID
- Karin, Michael
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2000-04
- Volume
- 18
- Issue
- 1
- Pages
- 621-663
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2147921405
- Cited by
- 4,766
- References
- 243
- Citations by year
- 2026: 78 · 2025: 109 · 2024: 86 · 2023: 101 · 2022: 114 · 2021: 112 · 2020: 129 · 2019: 114 · 2018: 129 · 2017: 153 · 2016: 156 · 2015: 135 · 2014: 186 · 2013: 201 · 2012: 194
- FWCI
- 22.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01 CA76188, R01CA076188)
- National Institute of Allergy and Infectious Diseases (R01AI043477, R01 AI43477)
- National Institute of Environmental Health Sciences (R37ES004151, R37 ES04151)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- NF-κB, IκB phosphorylation, ubiquitination, IκB kinase, IKKα, IKKβ, E3 ubiquitin ligase, proteolysis, NF-κB nuclear translocation, TNF signaling, IL-1 signaling, Rel family transcription factors, inflammation, transcriptional regulation
- MeSH terms
- NF-KappaB Inhibitor alpha, Amino Acid Sequence, Animals, DNA-Binding Proteins, Humans, Molecular Sequence Data, Phosphorylation, Transcription Factors, Ubiquitins, Signal Transduction, Down-Regulation, NF-kappa B, Protein Serine-Threonine Kinases, I-kappa B Proteins, I-kappa B Kinase, NF-kappa B p50 Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review